Ethical support for surfactant, positive pressure, and oxygenation randomized trial (SUPPORT)

Journal of Pediatrics

Volumn 163, Issue 5, 2013, Pages 1498-1499

  Fanaroff, Jonathan M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SURFACTANT;

ARTERIAL BLOOD; CEREBRAL PALSY; CYANOSIS; ETHICS; HAWTHORNE EFFECT; HUMAN; INFORMED CONSENT; INTENSIVE CARE; NOTE; OXYGEN SATURATION; OXYGENATION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA;

SUPPORT; SURFACTANT, POSITIVE PRESSURE, AND OXYGENATION RANDOMIZED TRIAL;

CONTINUOUS POSITIVE AIRWAY PRESSURE; ETHICS COMMITTEES, RESEARCH; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MULTICENTER STUDIES AS TOPIC; NATIONAL INSTITUTES OF HEALTH (U.S.); OXIMETRY; OXYGEN; PATIENT SAFETY; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINOPATHY OF PREMATURITY; UNITED STATES;

EID: 84886714757     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.06.037     Document Type: Note

References (12)

1. SUPPORT Study Group of the Eunice Kennedy shriver NICHD Neonatal Research Network Target ranges of oxygen saturation in extremely preterm infants N Engl J Med 362 2010 1959 1969
2. Carome, Michael A, Wolfe S (Public Citizen). Letter to The Honorable Kathleen Sebelius (Secretary, Department of Health and Human Services). 2013 Apr 10. Available at: http://www.citizen.org/documents/2111.pdf. Accessed April 15, 2013.
3. A.F. Robertson Reflections on errors in neonatology: I. The "hands-off" years, 1920-1950 J Perinatol 23 2003 48 55
4. Buchanan LR. (Compliance Oversight Coordinator, Department of Health & Human Services, Office for Human Research Protections). Letter to Richard B. Marchase, PhD (V.P. for Research and Economic Development, University of Alabama at Birmingham). 2013 Mar 7. Available at: http://www.hhs.gov/ohrp/detrm- letrs/YR13/mar13a.pdf. Accessed April 15, 2013.
5. D. Bolton, and K. Cross Further observations on cost of preventing retrolental fibroplasia Lancet 302 1974 445 448
6. D. Magnus, and A.L. Caplan Risk, consent, and SUPPORT N Engl J Med 368 2013 1864 1865
7. L.M. Askie, D.J. Henderson-Smart, and H. Ko Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants Cochrane Database Syst Rev 1 2009 CD001077
8. B. Freedman Equipoise and the ethics of clinical research N Engl J Med 317 1987 141 145
9. B. Schmidt, P. Gillie, C. Caco, J. Roberts, and R. Roberts Do sick newborn infants benefit from participation in a randomized clinical trial? J Pediatr 134 1999 151 155
10. D. DeAmici, C. Kiersy, F. Ramajoli, L. Brustia, and P. Politi Impact of the Hawthorne effect in a longitudinal clinical study: the case of anesthesia Control Clin Trial 21 2000 103 114
11. Comment by a2pam from The Diane Rehm Show-Clinical Trials and Premature Babies. Aired April 17, 2013. Available at: http://thedianerehmshow.org/shows/ 2013-04-17/clinical-trials-and-premature-babies. Accessed June 8, 2013.
12. C.H. Cole, K.W. Wright, W. Tarnow-Mordi, and D.L. Phelps Resolving our uncertainty about oxygen therapy Pediatrics 112 2003 1415 1419